The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer

被引:0
|
作者
Nielsen, Birgitte [1 ,3 ]
Albregtsen, Fritz [1 ,2 ]
Kildal, Wanja [1 ,3 ]
Abeler, Vera M. [4 ]
Kristensen, Gunnar B. [1 ,5 ]
Danielsen, Havard E. [1 ,2 ,3 ]
机构
[1] Oslo Univ Hosp, Radiumhosp, Inst Med Informat, N-0310 Oslo, Norway
[2] Univ Oslo, Dept Informat, N-0316 Oslo, Norway
[3] Univ Oslo, Ctr Canc Biomed, Oslo, Norway
[4] Oslo Univ Hosp, Dept Pathol, N-0310 Oslo, Norway
[5] Oslo Univ Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
关键词
Adaptive texture features; early stage ovarian cancer; nuclear texture analysis; pattern classification; prognostic marker; FEATURE-SELECTION; FEATURE VECTORS; DNA ANALYSIS; DYSPLASIA; WOMEN;
D O I
10.1155/2012/538479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Nuclear texture analysis gives information about the spatial arrangement of the pixel gray levels in a digitized microscopic nuclear image, providing texture features that may be used as quantitative tools for prognosis of human cancer. The aim of the study was to evaluate the prognostic value of adaptive nuclear texture features in early stage ovarian cancer. Methods: 246 cases of early stage ovarian cancer were included in the analysis. Isolated nuclei (monolayers) were prepared from 50 mu m tissue sections and stained with Feulgen-Schiff. Local gray level entropy was measured within small windows of each nuclear image and stored in gray level entropy matrices. A compact set of adaptive features was computed from these matrices. Results: Univariate Kaplan-Meier analysis showed significantly better relapse-free survival (p < 0.001) for patients with low adaptive feature values compared to patients with high adaptive feature values. The 10-year relapse-free survival was about 78% for patients with low feature values and about 52% for patients with high feature values. Adaptive features were found to be of independent prognostic significance for relapse-free survival in a multivariate analysis. Conclusion: Adaptive nuclear texture features from entropy matrices contain prognostic information and are of independent prognostic significance for relapse-free survival in early stage ovarian cancer.
引用
收藏
页码:305 / 314
页数:10
相关论文
共 29 条
  • [21] Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
    Bradley, R.
    Braybrooke, J.
    Gray, R.
    Hills, R. K.
    Liu, Z.
    Pan, H.
    Peto, R.
    Dodwell, D.
    McGale, P.
    Taylor, C.
    Bergh, J.
    Swain, S.
    Francis, P. A.
    Gnant, M.
    Perrone, F.
    Regan, M. M.
    LANCET ONCOLOGY, 2022, 23 (03): : 382 - 392
  • [22] Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
    Schulz, Christoph
    Heinemann, Volker
    Heinrich, Kathrin
    Haas, Michael
    Holch, Julian W.
    Fraccaroli, Alessia
    Held, Swantje
    von Einem, Jobst C.
    Modest, Dominik P.
    von Weikersthal, Ludwig Fischer
    Kullmann, Frank
    Moehler, Markus
    Scheithauer, Werner
    Jung, Andreas
    Stintzing, Sebastian
    ANTI-CANCER DRUGS, 2020, 31 (08) : 856 - 865
  • [23] Aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor positive early stage breast cancer treated with ovarian suppression: A patient level meta-analysis of 7,030 women in four randomised trials
    Bradley, Rosie
    Braybrooke, Jeremy
    Gray, Richard
    Hills, Robert K.
    Lui, Zulian
    Pan, Hongchao
    Peto, Richard
    Bergh, Jonas
    Swain, Sandra M.
    Francis, Prudence
    Gnant, Michael
    Perrone, Francesco
    Regan, Meredith M.
    CANCER RESEARCH, 2022, 82 (04)
  • [25] Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
    Braybrooke, Jeremy
    Bradley, Rosie
    Gray, Richard
    Hills, Robert K.
    Pan, Hongchao
    Peto, Richard
    Dodwell, David
    McGale, Paul
    Taylor, Carolyn
    Aihara, Tomohiko
    Anderson, Stewart
    Yothers, Greg
    Blum, Joanne
    O'Shaughnessy, Joyce
    Cardoso, Fatima
    Chen, Xiaosong
    Crown, John
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Friedl, Thomas W. P.
    Janni, Wolfgang
    Harbeck, N.
    Mamounas, Eleftherios
    Narui, K.
    Nitz, Ulrike
    Norton, Larry
    Piccart, Martine
    Robert, Nicholas
    Shao, Zhi-Ming
    Yu, Ke-Da
    Slamon, Dennis
    Sparano, Joseph
    Watanabe, Toru
    Bergh, Jonas
    Swain, Sandra
    Berry, R.
    Boddington, C.
    Bradley, R.
    Clarke, M.
    Davies, C.
    Davies, L.
    Dodwell, D.
    Duane, F.
    Evans, V.
    Gay, J.
    Gettins, L.
    Godwin, J.
    Gray, R.
    Hills, R. K.
    James, S.
    LANCET, 2023, 401 (10384): : 1277 - 1292
  • [26] PROGNOSTIC VALUE OF EARLY OBJECTIVE TUMOR RESPONSE (EOTR) TO FIRST LINE SYSTEMIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS OF RANDOMIZED TRIALS FROM THE ARCAD DATABASE
    Sommeijer, Dirkje W.
    Shi, Qian
    Meyer, Jeffrey
    Sjoquist, Katrin M.
    Hoff, Paolo M.
    Seymour, Matthew T.
    Cassidy, Jim
    Goldberg, Richard
    Douillard, Jean-Yves
    Hecht, J. Randolph
    Hurwitz, Herbert
    Tournigand, Christophe
    Tebbutt, Niall C.
    Aranda, Enrique
    Souglakos, John
    Kabbinavar, Fairooz F.
    Chibaudel, Benoist
    De Gramont, Aimery
    Sargent, Daniel J.
    Zalcberg, John
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 76 - 76
  • [27] Prognostic value of early objective tumor response (EOTR) to first-line systemic therapy in metastatic colorectal cancer (mCRC): Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database.
    Sommeijer, Dirkje Willemien
    Shi, Qian
    Meyers, Jeffrey P.
    Sjoquist, Katrin Marie
    Hoff, Paulo Marcelo
    Seymour, Matthew T.
    Cassidy, James
    Goldberg, Richard M.
    Douillard, Jean-Yves
    Hecht, J. Randolph
    Hurwitz, Herbert
    Tournigand, Christophe
    Tebbutt, Niall C.
    Aranda, Enrique
    Souglakos, John
    Kabbinavar, Fairooz F.
    Chibaudel, Benoist
    De Gramont, Aimery
    Sargent, Daniel J.
    Zalcberg, John Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five mammella interGruppo (MIG) and gruppo italiano mammella (GIM) randomized clinical trials (RCTs)
    Soldato, Davide
    Blondeaux, Eva
    Bruzzone, Marco
    Mura, Silvia
    De laurentiis, Michelino
    Turletti, Anna
    De Placido, Sabino
    Bisagni, Giancarlo
    Rimanti, Anita
    Michelotti, Andrea
    Fabi, Alessandra
    Russo, Antonio
    Gori, Stefania
    Durando, Antonio
    Marta, Guilherme Nader
    de Azambuja, Evandro
    Di Meglio, Antonio
    Vaz-Luis, Ines
    Lambertini, Matteo
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+early-stage breast cancer patients who received trastuzumab: Evidence from a real-world study with long-term follow-up
    Ju, Jie
    Gao, Song-Lin
    Wang, Jia-Yu
    Sang, Die
    Kang, Yi-Kun
    Wang, Xue
    Yue, Jian
    Shuai, You
    Qi, Yi-Xin
    Yuan, Peng
    THORACIC CANCER, 2024, 15 (06) : 439 - 447